Bac8.5

Bacopa Monnieri

Bacopa Monnieri

An ancient Ayurvedic herb shown in clinical studies to support memory and learning, particularly with consistent use over 8-12 weeks.

mentalmemorylearningcognitionanxiety
Last reviewed: January 1, 2025
8.5/10
40+ studies
Evidence
high
Safety
300-450mg daily (standardized to 50% bacosides)
Dose
8-12 weeks
Time to Effect
Bacognize® or Synapsa® standardized extract
Best Form

Bacopa monnieri is a traditional Ayurvedic herb with strong evidence for memory enhancement. Unlike stimulants, it works gradually by supporting synaptic communication and protecting neurons. Studies consistently show improvements in memory formation and recall after 8-12 weeks of use.

Mechanisms of Action

🔗
Synaptic Enhancement

Strengthens connections between neurons

🛡️
Neuroprotection

Protects brain cells from oxidative stress

⚡
Acetylcholine Modulation

Supports the neurotransmitter for learning

Recommended Dose

300-450mg daily (standardized to 50% bacosides)

300mg600mg

Optimal Timing

  • With fatty meal for absorption

Take with food

Best Form

Bacognize® or Synapsa® standardized extract

Alternatives: BacoMind, Generic standardized extract

Must be standardized to at least 50% bacosides. Branded extracts (Bacognize, Synapsa) are most studied. Quality varies with generics.

Duration

Minimum: 8 weeks

Optimal: 12 weeks

Cycling: Not required

Note: Fat-soluble; must be taken with food containing fat for proper absorption. Can cause drowsiness initially, so evening dosing may be preferred.

Personalized Dosage Calculator

Get a dosage recommendation tailored to your body weight, age, goals, and health profile.

Set up your health profile for personalized recommendations

🧠
Better Memory

Enhanced memory formation, retention, and recall

8-12 weeks
80% of users notice thispositive
📖
Faster Learning

Improved ability to acquire new information

8-12 weeks
70% of users notice thispositive
😴
Initial Drowsiness

Some experience tiredness in first weeks

First 2 weeks
30% of users notice thistrade-off
😖
GI Discomfort

Stomach upset if taken without food

First week
25% of users notice thistrade-off
High SafetyMax safe dose: Up to 600mg/day appears safe; higher doses not more effective
🔴
Pregnant/nursing

Not recommended; insufficient safety data

🟡
Children

Traditional use in children; modern studies limited

Who Should NOT Take This

  • Thyroid disorders (may affect thyroid hormones)
  • Stomach ulcers (may increase stomach acid)

Drug Interactions

Thyroid medicationsmoderate

May affect thyroid hormone levels

Anticholinergic drugsmild

May counteract effects

Sedativesmild

May have additive sedating effects

Possible Side Effects

GI upset/nauseauncommon

Tip: Always take with fatty meal

Fatigue/drowsinessuncommon

Tip: Often resolves after first 2 weeks; try evening dosing

Dry mouthrare

Tip: Stay hydrated

Warnings

  • Requires 8-12 weeks for full effects
  • Must take with fat for absorption
  • Initial drowsiness typically resolves

Top studies from 40+ peer-reviewed papers

systematic-review
DOI

Al Shahab S et al. • Nutrients (2025)

“The evidence revealed the potential use of supplements as complementary ADHD treatments under clinical guidance.”
Key Findings:
  • The evidence revealed the potential use of supplements as complementary ADHD treatments under clinical guidance.
  • The limited effect of supplements cannot replace the well-documented efficacy of stimulants for ADHD treatment.
  • Additional studies are needed to ascertain the most effective dosages and the safety of these supplements as adjunctive treatments for ADHD.
systematic-reviewn=103
DOI

Ayilara GO et al. • Nutritional neuroscience (2025)

“It is recommended that additional research elucidating the effects of Brahmi in other models of schizophrenia and the possible mechanisms of action be conducted.”
Key Findings:
  • Schizophrenia is a psychotic disorder affecting approximately 0.32% of the global population.
  • Data analysis was done by using themes.
  • The review found that Brahmi could reverse positive, negative, and cognitive symptoms of schizophrenia.
  • It does this by changing the glutamatergic pathway and GABAergic transmission, lowering MDA levels, raising GSH levels, slowing down the activity of acetylcholinesterase (AchE), and maintaining the density of neurones.
systematic-review
DOI

Gościniak A et al. • Nutrients (2025)

“Further research is needed to determine optimal dosages and ensure safety, especially for pregnant and breastfeeding women.”
Key Findings:
  • Animal studies have shown promising results in reducing symptoms and protecting against neurodegeneration.
  • Concerning safety, Bacopa monnieri has been found to be generally non-toxic, with no serious side effects reported.
  • However, interactions with certain medications and contraindications in conditions like hyperthyroidism should be considered.
  • Further research is needed to determine optimal dosages and ensure safety, especially for pregnant and breastfeeding women.
systematic-review
DOI

Lorca C et al. • Critical reviews in food science and nutrition (2023)

“Together, the results from the compiled studies highlight the nootropic effects and the inconsistencies regarding PDNs that require further research.Supplemental data for this article is available online at https://doi.org/10.1080/10408398.2021.2021137.”
Key Findings:
  • Bacopa monnieri improves language, learning and memory.
  • Withania somnifera (Ashwagandha) modulates anxiety and social-related cognitions.
  • Caffeine enhances attention and executive functions.
  • Together, the results from the compiled studies highlight the nootropic effects and the inconsistencies regarding PDNs that require further research.Supplemental data for this article is available online at https://doi.org/10.1080/10408398.2021.2021137.
systematic-review
DOI

Lopresti AL et al. • Nutritional neuroscience (2022)

“For most phytonutrients, the effects of supplementation on HPA-axis activity in humans is unclear.”
Key Findings:
  • For most phytonutrients, the effects of supplementation on HPA-axis activity in humans is unclear.
  • Before more definitive conclusions about the effects of phytonutrients on the HPA-axis can be made, further research is required.
  • Further research warranted to confirm findings
40
Total Studies
8.9/10
Avg Quality
14-2,017
Sample Size Range
2001-2025
Research Span

Study Type Distribution

Systematic Review
21
RCT
16
Crossover
2
Meta-Analysis
1

This information is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare provider before starting any supplement.